HDL载脂蛋白组学评分与冠状动脉粥样硬化及心血管死亡的相关性
本研究基于CASABLANCA队列中943例无既往心肌梗死并接受冠状动脉造影的参与者,采用靶向质谱检测HDL相关载脂蛋白A-1、C-1、C-2、C-3、C-4并构建复合HDL载脂蛋白组学评分(pCAD)。结果显示pCAD评分与梗阻性冠心病存在独立关联,且在梗阻性冠心病患者中可能与心血管死亡独立相关。
要点
- HDL载脂蛋白组学评分与梗阻性冠心病存在独立于传统危险因素的关联。
- 该评分对梗阻性冠心病的C-index为0.63(95%CI 0.59–0.67)。
- 在梗阻性冠心病患者中,评分与心血管死亡存在关联。
核心结论
- HDL载脂蛋白组学评分与冠状动脉粥样硬化存在独立于循环apoA-1、apoB及传统心血管危险因素的关联。
- 在合并冠心病的个体中,该评分可能与心血管死亡独立相关。
研究设计与样本
- 研究纳入CASABLANCA研究中943例无既往心肌梗死并接受冠状动脉造影的参与者。
- 采用靶向质谱检测HDL相关载脂蛋白A-1、C-1、C-2、C-3、C-4,构建复合HDL载脂蛋白组学评分(pCAD)。
- 评估pCAD评分与梗阻性冠心病(≥1支血管狭窄≥70%)及4年随访期间心血管结局的关联。
主要发现
- 587例(62.2%)患者存在冠状动脉狭窄。
- pCAD评分与梗阻性冠心病存在关联(OR 1.39;95%CI 1.14–1.69;p<0.001),独立于包括循环apoA-1和apoB在内的传统心血管危险因素。
- pCAD评分对梗阻性冠心病的C-index为0.63(95%CI 0.59–0.67)。
- pCAD评分与全部个体的心血管死亡无显著关联(HR 1.24;95%CI 0.93–1.66;p=0.15)。
- 在梗阻性冠心病患者中,pCAD评分与心血管死亡存在关联证据(HR 1.48;95%CI 1.07–2.05;p=0.019)。
临床怎么用
- HDL载脂蛋白组学评分可作为评估冠状动脉粥样硬化风险的补充工具,其信息独立于传统血脂指标。
- 在已确诊梗阻性冠心病的患者中,该评分有助于识别心血管死亡风险较高者。
局限性
- 研究为接受冠状动脉造影的特定人群,结果外推需谨慎。
- pCAD评分对梗阻性冠心病的C-index为0.63,区分能力有限。
- pCAD与全部个体心血管死亡的关联未达统计学显著性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Concentrations of circulating apolipoproteins are strongly linked to risk for coronary artery disease (CAD). The relative importance of the additional knowledge of apolipoprotein concentrations within specific lipoprotein species for CAD risk prediction is limited. OBJECTIVES: This study sought to evaluate the performance of a high-density lipoprotein (HDL) apolipoproteomic score, based on targeted mass spectrometry of HDL-associated apolipoproteins, for the detection of angiographic CAD and outcomes. METHODS: HDL-associated apolipoprotein (apo) A-1, apoC-1, apoC-2, apoC-3, and apoC-4 were measured in 943 participants without prevalent myocardial infarction (MI) referred for coronary angiography in the CASABLANCA (Catheter Sampled Blood Archive in Cardiovascular Diseases) study. A composite HDL apolipoproteomic score (pCAD) was associated with likelihood of obstructive CAD (≥70% lesion in ≥1 vessel) and with incident cardiovascular outcomes over 4-year follow-up. RESULTS: There were 587 (62.2%) patients with coronary stenosis. The pCAD score was associated with the presence of obstructive CAD (odds ratio: 1.39; 95% confidence interval [CI]: 1.14 to 1.69; p < 0.001), independently of conventional cardiovascular risk factors including circulating plasma apoA-1 and apoB. The C-index for pCAD was 0.63 (95% CI: 0.59 to 0.67) for the presence of obstructive CAD. Although pCAD was not associated with cardiovascular mortality among all individuals (hazard ratio: 1.24; 95% CI: 0.93 to 1.66; p = 0.15), there was evidence of association for individuals with obstructive CAD (hazard ratio: 1.48; 95% CI: 1.07 to 2.05; p = 0.019). CONCLUSIONS: An HDL apolipoproteomic score is associated with the presence of CAD, independent of circulating apoA-1 and apoB concentrations and other conventional cardiovascular risk factors. Among individuals with CAD, this score may be independently associated cardiovascular death. (The CASABLANCA Study: Catheter Sampled Blood Archive in Cardiovascular Diseases [CASABLANCA]; NCT00842868).
引用
- Natarajan P, Collier TS, Jin Z, et al. Association of an HDL Apolipoproteomic Score With Coronary Atherosclerosis and Cardiovascular Death. J Am Coll Cardiol. 2019. PMID: 31047001. doi:10.1016/j.jacc.2019.01.073
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。